"Minocycline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Descriptor ID |
D008911
|
MeSH Number(s) |
D02.455.426.559.847.562.900.550 D04.615.562.900.550
|
Concept/Terms |
Minocycline Hydrochloride- Minocycline Hydrochloride
- Hydrochloride, Minocycline
- Minocycline Monohydrochloride
- Monohydrochloride, Minocycline
|
Below are MeSH descriptors whose meaning is more general than "Minocycline".
Below are MeSH descriptors whose meaning is more specific than "Minocycline".
This graph shows the total number of publications written about "Minocycline" by people in this website by year, and whether "Minocycline" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Minocycline" by people in Profiles.
-
Extended antibiotic resistance in carbapenemase-producing Klebsiella pneumoniae: A case series. Am J Infect Control. 2016 09 01; 44(9):1050-2.
-
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep; 13(9):785-96.
-
Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012; 54:297-335.
-
Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol. 2010 Oct 11; 10:91.
-
TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis. 2007 Apr; 26(1):36-46.
-
Strategies for preventing catheter-related bloodstream infections: the role of new technologies. Crit Care Med. 2006 Mar; 34(3):905-7.
-
In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3):253-5.